Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma

NCT03961867 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

440

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Docetaxel
DRUG: Oxaliplatin

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University